Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
JAK2 mutation
i
Other names:
JTK10, THCYT3, JAK2, Janus Kinase 2, Tyrosine-Protein Kinase JAK2, JAK-2
Associations
(4)
News
Trials
C2 | Sensitive
C3 | Sensitive
D | Sensitive
C2 | Resistant
C3 | Resistant
D | Resistant
Show legend
Include preclinical:
Drug categories
Tyrosine Kinase Inhibitors
Serine-Threonine Kinase Inhibitors
BCL Inhibitors
Cancel
Acute Myelogenous Leukemia
Leukemia
ruxolitinib
C2
JAK2 mutation
|
Acute Myelogenous Leukemia
|
ruxolitinib
C2
JAK2 mutation
|
Leukemia
|
ruxolitinib
LY3009120
C3
JAK2 mutation
|
Acute Myelogenous Leukemia
|
LY3009120
DT2216
D
JAK2 mutation
|
Acute Myelogenous Leukemia
|
DT2216
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
